The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
- PMID: 23648364
- DOI: 10.1016/j.molmed.2013.04.002
The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
Abstract
The aggregation of the protein alpha-synuclein (α-SYN) is believed to be a critical event in Parkinson's disease (PD). α-SYN is characterized by a remarkable conformational plasticity, adopting different conformations depending on the environment. In vitro, α-SYN lacks a well-defined structure. Therefore, it was classified as an 'intrinsically disordered protein'. A debate has recently begun over how α-SYN behaves in the cell: is it an intrinsically disordered protein or a stable tetramer with a low propensity for aggregation? In this review, we discuss the aggregation of α-SYN and describe factors that influence this process and their potential relevance in PD pathogenesis. We address the ways in which aggregated α-SYN mediates toxicity and might lead to PD, and propose possible therapeutic strategies.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.Biochim Biophys Acta Proteins Proteom. 2019 Oct;1867(10):890-908. doi: 10.1016/j.bbapap.2019.03.001. Epub 2019 Mar 7. Biochim Biophys Acta Proteins Proteom. 2019. PMID: 30853581 Review.
-
α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling.Mol Neurobiol. 2015;51(3):1417-31. doi: 10.1007/s12035-014-8818-2. Epub 2014 Aug 20. Mol Neurobiol. 2015. PMID: 25139280 Review.
-
The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.Biochemistry. 2013 Oct 8;52(40):6925-7. doi: 10.1021/bi400999d. Epub 2013 Sep 23. Biochemistry. 2013. PMID: 24047453
-
The aggregation and fibrillation of alpha-synuclein.Acc Chem Res. 2006 Sep;39(9):628-34. doi: 10.1021/ar050073t. Acc Chem Res. 2006. PMID: 16981679 Review.
-
Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.Curr Protein Pept Sci. 2017;18(7):656-676. doi: 10.2174/1389203717666160314151706. Curr Protein Pept Sci. 2017. PMID: 26972727 Review.
Cited by
-
Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease.Cell Mol Life Sci. 2014 Sep;71(18):3507-21. doi: 10.1007/s00018-014-1634-z. Epub 2014 May 7. Cell Mol Life Sci. 2014. PMID: 24803005 Free PMC article. Review.
-
Malleable nature of mRNA-protein compositional complementarity and its functional significance.Nucleic Acids Res. 2015 Mar 31;43(6):3012-21. doi: 10.1093/nar/gkv166. Epub 2015 Mar 8. Nucleic Acids Res. 2015. PMID: 25753660 Free PMC article.
-
Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.Int J Mol Sci. 2018 Jan 24;19(2):336. doi: 10.3390/ijms19020336. Int J Mol Sci. 2018. PMID: 29364151 Free PMC article. Review.
-
Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease.Front Neurosci. 2015 Nov 12;9:433. doi: 10.3389/fnins.2015.00433. eCollection 2015. Front Neurosci. 2015. PMID: 26617485 Free PMC article. Review.
-
Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration.Mol Neurodegener. 2015 Jun 23;10:23. doi: 10.1186/s13024-015-0017-8. Mol Neurodegener. 2015. PMID: 26099628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
